In particular, T2DM is a chronic and metabolic disease characterised by defects in pancreatic insulin secretion and (or) insulin effect on target tissues, generating a persistent state of hyperglycaemia, inducing metabolic alteration, cell-death and inflammation. This evidence concerns the gene INS and metabolic disease.